Literature DB >> 30054903

Prolonged lipopolysaccharide exposure induces transient immunosuppression in BV2 microglia.

Krishna Sundar Twayana1, Namrata Chaudhari1, Palaniyandi Ravanan1.   

Abstract

Continuous pre-exposure of immune cells to low level of inflammatory stimuli makes them hyporesponsive to subsequent exposure. This pathophysiological adaptation; known as endotoxin tolerance is a general paradigm behind several disease pathogenesis. Current study deals with this immunosuppression with respect to BV2 microglia. We attempted to investigate their immune response under prolonged endotoxin exposure and monitor the same upon withdrawal of the stimuli. BV2 microglia cells were maintained under continual exposure of lipopolysaccharide (LPS) for weeks with regular passage after 72 hr (prolonged LPS exposed cells [PLECs]). PLECs were found to be immunosuppressed with diminished expression of proinflammatory cytokines (IL6, IL1β, TNF-α, and iNOS) and production of nitric oxide, as compared to once LPS exposed cells. Upon remaintenance of cells in normal media without LPS exposure (LPS withdrawal cells [LWCs]), the induced immunosuppression reversed and cells started responding to inflammatory stimuli; revealed by significant expression of proinflammatory cytokines. LWCs showed functional similarities to never LPS exposed cells (NLECs) in phagocytosis activity and their response to anti-inflammatory agents like dexamethasone. Despite their immunoresponsiveness, PLECs were inflamed and showed higher autophagy rate than NLECs. Additionally, we investigated the role of inhibitor of apoptotic proteins (IAPs) in PLECs to understand whether IAPs aids in the survival of microglial cells under stress conditions. Our results revealed that cIAP1 and cIAP2 are induced in PLECs which might play a role in retaining the viability. Furthermore, antagonism of IAPs has significantly induced cell death in PLECs suggesting the role of IAPs in microglial survival under stress condition. Conclusively, our data suggest that continuous exposure of BV2 microglia cells to LPS results in transient immunosuppression and indicates the involvement of IAPs in retaining their viability under inflammatory stress.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  chronic inflammation; cytokines; endotoxin tolerance; transient immunosuppression

Year:  2018        PMID: 30054903     DOI: 10.1002/jcp.27064

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Upregulated TSG-6 Expression in ADSCs Inhibits the BV2 Microglia-Mediated Inflammatory Response.

Authors:  Yang Hu; Gaigai Li; Ye Zhang; Na Liu; Ping Zhang; Chao Pan; Hao Nie; Qi Li; Zhouping Tang
Journal:  Biomed Res Int       Date:  2018-11-21       Impact factor: 3.411

2.  Manifestation of lipopolysaccharide-induced tolerance in neuro-glial primary cultures of the rat afferent somatosensory system.

Authors:  Franz Nürnberger; Stephan Leisengang; Daniela Ott; Jolanta Murgott; Rüdiger Gerstberger; Christoph Rummel; Joachim Roth
Journal:  Inflamm Res       Date:  2021-02-13       Impact factor: 4.575

3.  A unique hybrid characteristic having both pro- and anti-inflammatory phenotype transformed by repetitive low-dose lipopolysaccharide in C8-B4 microglia.

Authors:  Haruka Mizobuchi; Kazushi Yamamoto; Shoko Tsutsui; Masafumi Yamashita; Yoko Nakata; Hiroyuki Inagawa; Chie Kohchi; Gen-Ichiro Soma
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

4.  Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells.

Authors:  Sarah Thomas Broome; Teagan Fisher; Alen Faiz; Kevin A Keay; Giuseppe Musumeci; Ghaith Al-Badri; Alessandro Castorina
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

5.  Reduced TREM2 activation in microglia of patients with Alzheimer's disease.

Authors:  Yuumi Okuzono; Hiroyuki Sakuma; Shuuichi Miyakawa; Masataka Ifuku; Jonghun Lee; Debashree Das; Antara Banerjee; Yang Zhao; Koji Yamamoto; Tatsuya Ando; Shuji Sato
Journal:  FEBS Open Bio       Date:  2021-09-28       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.